Search - tctmd.com

Displaying 201 - 220 of 355

Sort: Relevancy | Date

Lower Hypertension Range Tied to Heightened CVD Risk in Younger Adults

News Daily News

Lower Hypertension Range Tied to Heightened CVD Risk in Younger Adults

November 08, 2018

Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors

News Daily News

Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors

October 30, 2018

Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US

News Daily News

Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US

Yael L. Maxwell

October 19, 2018

Church-Based Lifestyle Intervention Shows Promise for Lowering BP in Hypertensive African-Americans

News Daily News

Church-Based Lifestyle Intervention Shows Promise for Lowering BP in Hypertensive African-Americans

October 09, 2018

Statin Benefits: Yes for CVD but No for Everything Else, Says New Review

News Daily News

Statin Benefits: Yes for CVD but No for Everything Else, Says New Review

Michael O'Riordan

October 08, 2018

Dapagliflozin Gets Partial Win in DECLARE-TIMI 58

News Daily News

Dapagliflozin Gets Partial Win in DECLARE-TIMI 58

October 02, 2018

Good INR Control on Warfarin Doesn’t Necessarily Predict Future Success, Outcomes

News Daily News

Good INR Control on Warfarin Doesn’t Necessarily Predict Future Success, Outcomes

September 13, 2018

Newly Defined Stage 1 Hypertension Tied to CVD Risk in Younger Chinese Adults

News Daily News

Newly Defined Stage 1 Hypertension Tied to CVD Risk in Younger Chinese Adults

September 07, 2018

CKD Patients With Left Main Disease See Similar Outcomes at 3 Years After PCI vs CABG: EXCEL

News Daily News

CKD Patients With Left Main Disease See Similar Outcomes at 3 Years After PCI vs CABG: EXCEL

August 09, 2018

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

July 30, 2018

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

News Daily News

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

July 02, 2018

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

News Daily News

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

June 19, 2018

New European Hypertension Guidelines Not in Harmony With US Guidance

News Daily News

New European Hypertension Guidelines Not in Harmony With US Guidance

June 11, 2018

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

News Daily News

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Michael O'Riordan

May 01, 2018

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

News Daily News

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Michael O'Riordan

April 05, 2018

Unplanned Readmissions Within 30 Days Post-PCI Affect Nearly One in 10 US Patients

News Daily News

Unplanned Readmissions Within 30 Days Post-PCI Affect Nearly One in 10 US Patients

April 04, 2018

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

News Daily News

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

March 29, 2018

Less Aggressive HbA1c Targets Recommended by American College of Physicians

News Daily News

Less Aggressive HbA1c Targets Recommended by American College of Physicians

Michael O'Riordan

March 06, 2018

Multivessel PCI Improves Outcomes in STEMI Patients With Cardiogenic Shock: Korean Registry

News Daily News

Multivessel PCI Improves Outcomes in STEMI Patients With Cardiogenic Shock: Korean Registry

February 23, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.